Announcements Trials
Browse Landscape

Status

Completed 35Recruiting 12Active not recruiting 5Unknown 4Terminated 4Enrolling by invitation 2Withdrawn 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 37Breast 5Gastrointestinal 3Thoracic 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Dermatologic 2NET 1Head & Neck 1Endocrine 1CNS 1

Conditions

Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 6Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 4Lymphoma 4Leukemia 4Neoplasms 3Multiple Myeloma 3Melanoma 3Lymphoma, B-Cell 3Thrombocytopenia 2Prostatic Neoplasms 2Pain 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, B-Cell 2Hematologic Diseases 2Acute Pain 2Wounds and Injuries 1Waldenstrom Macroglobulinemia 1Urogenital Diseases 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1

Interventions

Inosine Monophosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Prostatic Neoplasms × Other hematologic neoplasm × Clear all
NCT07328516 2026-06-05

Natural History Study of Early Life Exposures in Agriculture (ELEA)

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
64,277 enrolled
BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT07474051 2026-03-16

PERSIST

AvenCell Therapeutics, Inc.

Enrolling by invitation
178 enrolled
GenitourinaryLymphoidOther hematologic neoplasm

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡